Does EFGARTIGIMOD ALFA Cause Therapy non-responder? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Therapy non-responder have been filed in association with EFGARTIGIMOD ALFA (VYVGART). This represents 4.8% of all adverse event reports for EFGARTIGIMOD ALFA.
12
Reports of Therapy non-responder with EFGARTIGIMOD ALFA
4.8%
of all EFGARTIGIMOD ALFA reports
1
Deaths
8
Hospitalizations
How Dangerous Is Therapy non-responder From EFGARTIGIMOD ALFA?
Of the 12 reports, 1 (8.3%) resulted in death, 8 (66.7%) required hospitalization, and 3 (25.0%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EFGARTIGIMOD ALFA. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does EFGARTIGIMOD ALFA Cause?
Myasthenia gravis (46)
Off label use (39)
Drug ineffective (25)
Myasthenia gravis crisis (25)
Fatigue (22)
Pneumonia (20)
Muscular weakness (17)
Urinary tract infection (17)
Malaise (14)
Covid-19 (13)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which EFGARTIGIMOD ALFA Alternatives Have Lower Therapy non-responder Risk?
EFGARTIGIMOD ALFA vs EFGARTIGIMOD ALFA-FCAB
EFGARTIGIMOD ALFA vs EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC
EFGARTIGIMOD ALFA vs EFINACONAZOLE
EFGARTIGIMOD ALFA vs EFLORNITHINE
EFGARTIGIMOD ALFA vs EFMOROCTOCOG ALFA